This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heikkinen, T.
Right arrow Articles by Chonmaitree, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heikkinen, T.
Right arrow Articles by Chonmaitree, T.
Related Collections
Right arrow Infectious Disease & Immunity

PEDIATRICS Vol. 102 No. 2 August 1998, pp. 296-299

Serum Interleukin-6 in Bacterial and Nonbacterial Acute Otitis Media

Received Dec 11, 1997; accepted Feb 13, 1998.

Terho Heikkinen*, Faryal Ghaffar*, Anthony O. OkoroduduDagger , and Tasnee Chonmaitree*, Dagger

From the Departments of * Pediatrics and Dagger  Pathology, University of Texas Medical Branch, Galveston, Texas.

Background.  Increasing prevalence of antibiotic-resistant bacteria is a serious clinical problem that calls for reduction of unnecessary use of antibiotics. Acute otitis media (AOM) is the most common reason for antibiotic therapy in the United States. Approximately 30% of AOM cases do not have a bacterial etiology. Rapid identification of these cases could help withhold unnecessary antibiotic treatment.

Objective.  To determine the usefulness of serum levels of interleukin-6 (IL-6), an acute phase cytokine shown to be a reliable marker of neonatal bacterial infection, in differentiation between bacterial and nonbacterial AOM in children.

Study Design.  IL-6 was measured in stored serum samples from 184 children (mean age, 22 months) with AOM who were enrolled in antibiotic efficacy trials at our department. The samples were obtained at enrollment and at 9 to 12 days after initiation of antibiotic therapy. Sera from 21 uninfected children (mean age, 23 months) were used as controls. The etiology of AOM was determined by bacterial and viral cultures as well as respiratory syncytial virus antigen detection in the middle ear fluids obtained by tympanocentesis.

Results.  Bacterial etiology of AOM was confirmed in 125 children (68%), whereas in 59 children (32%) no bacterial pathogen could be detected in the middle ear fluid. Children with bacterial AOM had significantly higher IL-6 levels than those with nonbacterial AOM (median, 11.5 vs 3.7 pg/mL). However, this difference was almost entirely attributable to pneumococcal AOM specifically. IL-6 levels in children with AOM caused by Streptococcus pneumoniae were significantly higher (median, 40.1 pg/mL) than in AOM caused by Haemophilus influenzae (7.3 pg/mL) or Moraxella catarrhalis (6.8 pg/mL). At the cutoff value of 30 pg/mL, the specificity of IL-6 for detection of pneumococcal AOM was 91% with a sensitivity of 61%, but its sensitivity for detection of bacterial AOM in general was only 27%.

Conclusions.  Low levels of IL-6 do not rule out bacterial etiology of AOM in general; therefore, IL-6 is not sensitive enough as a marker of bacterial AOM. Surprisingly, serum IL-6 levels in pneumococcal AOM were significantly higher than the levels associated with other bacterial AOM, and serum IL-6 levels of >30 pg/mL were highly specific for pneumococcal AOM. These findings suggest a distinctive role for S pneumoniae in the pathogenesis of AOM.

Key words: interleukin-6, cytokines, acute otitis media, bacteria, virus, Creactive protein.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
M. M. Pettigrew and K. P. Fennie
Genomic Subtraction Followed by Dot Blot Screening of Streptococcus pneumoniae Clinical and Carriage Isolates Identifies Genetic Differences Associated with Strains That Cause Otitis Media
Infect. Immun., May 1, 2005; 73(5): 2805 - 2811.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
D. P. McCormick, K. A. Saeed, C. Pittman, C. D. Baldwin, N. Friedman, D. C. Teichgraeber, and T. Chonmaitree
Bullous Myringitis: A Case-Control Study
Pediatrics, October 1, 2003; 112(4): 982 - 986.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
G. Scharer, F. Zaldivar, G. Gonzalez, O. Vargas-Shiraishi, J. Singh, and A. Arrieta
Systemic Inflammatory Responses in Children with Acute Otitis Media Due to Streptococcus pneumoniae and the Impact of Treatment with Clarithromycin
Clin. Vaccine Immunol., July 1, 2003; 10(4): 721 - 724.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Melhus and A. F. Ryan
Expression of Cytokine Genes during Pneumococcal and Nontypeable Haemophilus influenzae Acute Otitis Media in the Rat
Infect. Immun., July 1, 2000; 68(7): 4024 - 4031.
[Abstract] [Full Text] [PDF]